Hello all, I'm a newbie and I'm having incredible difficulty understanding the difference between the DHF, DMR, and where the BOM (Bill of Materials) is supposed to fit into both of them. I would greatly appreciate some real-life examples, because all these vague regulatory definitions are of zero help when trying to do it in the real world.
I have an electrical medical device with a circuit board inside and its own software. It's a simple Class 2 device on the low-risk side. We coded the software ourselves. We're not building anything in-house. I'm purchasing everything (custom-made circuit board, hardware, a plastic shell, etc.) from third-party contract manufacturers, and it'll be send to a separate vendor for final assembly, packaging, and sterilization.
I read through the FDA regulations, webinars, and guidances on design controls. It says that the "Design Outputs" of the Design History File (DHF) are the assembly drawings, component drawings, and source code.
In this FDA webinar: fda DOT gov/media/89241/download
FDA states the following:
FDA states that the DMR includes "Device Specifications" which include the following:
A Bill of Materials (BOM) is a list of all the product's parts, right? In my DHF, I already have a traceability matrix that is listing all my part drawings as "Design Outputs" against my "Design Inputs" requirements. The way my project is working is that we'll create the part drawings ourselves (hardware, circuit boards, plastic shell, etc.), and send the part drawing along with a PO to a contract manufacturer to create the part for us. So the part drawings are the "Design Outputs" of the DHF. So the BOM is just a list of all our parts, each of which have an approved part drawing. So why wouldn't the BOM go into the DHF as well as the DMR?
On top of that, where is the cut-off between the DHR and DMR in terms of part drawings, selecting contract manufacturers, manufacturing parts for verification/validation testing, and then manufacturing finished product after FDA 510(k) approval? It seems to me that it's a giant mish-mash of unhelpful vague nothingness. I keep reading that the DHF and DMR are often conflated at different companies, there's no requirement to actually have them separate, and that the "Design Transfer" process can start at any point (because you need to manufacture parts for verification/validation testing in order to get FDA approval in the first place).
I have an electrical medical device with a circuit board inside and its own software. It's a simple Class 2 device on the low-risk side. We coded the software ourselves. We're not building anything in-house. I'm purchasing everything (custom-made circuit board, hardware, a plastic shell, etc.) from third-party contract manufacturers, and it'll be send to a separate vendor for final assembly, packaging, and sterilization.
I read through the FDA regulations, webinars, and guidances on design controls. It says that the "Design Outputs" of the Design History File (DHF) are the assembly drawings, component drawings, and source code.
In this FDA webinar: fda DOT gov/media/89241/download
FDA states the following:
- Design Outputs are included in premarket submissions as Device Specifications.
- The finished design output is the basis for the Device Master Record (DMR).
- The total finished design output consists of the device, its packaging, labeling, and the Device Master Record (DMR).
FDA states that the DMR includes "Device Specifications" which include the following:
- Bill of Materials
- Drawings and schematics
- List of Ingredients
- Component Specifications
- Material Composition
- Formulations
- Assemblies
- Software specifications
A Bill of Materials (BOM) is a list of all the product's parts, right? In my DHF, I already have a traceability matrix that is listing all my part drawings as "Design Outputs" against my "Design Inputs" requirements. The way my project is working is that we'll create the part drawings ourselves (hardware, circuit boards, plastic shell, etc.), and send the part drawing along with a PO to a contract manufacturer to create the part for us. So the part drawings are the "Design Outputs" of the DHF. So the BOM is just a list of all our parts, each of which have an approved part drawing. So why wouldn't the BOM go into the DHF as well as the DMR?
On top of that, where is the cut-off between the DHR and DMR in terms of part drawings, selecting contract manufacturers, manufacturing parts for verification/validation testing, and then manufacturing finished product after FDA 510(k) approval? It seems to me that it's a giant mish-mash of unhelpful vague nothingness. I keep reading that the DHF and DMR are often conflated at different companies, there's no requirement to actually have them separate, and that the "Design Transfer" process can start at any point (because you need to manufacture parts for verification/validation testing in order to get FDA approval in the first place).